The global focus on health & periodic cleanliness and the demand for improved healthcare products that can fulfil the need for several medical applications is generating the demand for medical foams. Medical foams have attained a significant reputation in the healthcare industry since the last two decades owing to their exceptional applications in medical practices. The utilization of medical foams in wound dressing, medical supports, prosthetic padding, medical aids, etc., and their characteristics that include softness, flexibility, absorbency and durability makes them inimitable in medical practices.
Medical foams are also used for the packaging of specialty products and medical devices as they deliver security against severe climatic conditions and any type of external resistance. Thus, they guarantee product safety during shipping and give a sense of confidence to manufacturers and consumers about the quality of the packaged product. Medical foams have made momentous contributions to the medical industry. Overall, the global medical foams market is expected to witness positive growth during the forecast period.
The rising global population and increasing health concerns among consumers regarding health and cleanliness is boosting the demand for high-quality medical-grade foam that is suitable for various medical applications. This factor is also expected to continue to drive the global medical foams market during the forecast period. The rapid expansion of the healthcare industry across the globe is also propelling the demand for medical foams, which is likely to fuel the growth of the global medical foam market. Furthermore, the usage of medical foams for the packaging of various medical devices and pharmaceutical products appears to be a key factor fuelling the growth of the medical foams market.
In March 2020, Bayer Material Science agreed to operate under the name Covestro. Covestro announced a cooperation agreement with Teknor Apex, a global plastics compounder. The agreement is to compound TPU and processed it on a global scale.
In December 2019, Rogers Corporation launched a product PORON SlimGrip Plus foam, made of polyurethane material with increased cohesive strength for ease of processing. The product has high level of compressibility and superior compression set resistance that makes it suitable for sealing applications with low compression requirements.
The study analyses Global Medical Foam market is based on form, material, application and geography.
Geographically, the study is comprised of the key countries of North America, Europe, Asia-Pacific and Rest of the World. Asia-Pacific is likely to account for the highest share of the total Medical Foam market revenue, followed by Europe and North America. The usage of rigid medical foams in orthotics, podiatric, hip protector pads, wheelchair pads and hygienic seating for protection and support is foreseen to contribute to the global medical foams market during the forecast period. Owing to their wide range of properties, medical foams will continue to play an important role in the future of science and medicine, which is also expected to contribute to the growth of the global medical foams market during the forecast period..
Some leading players operating in this market includes BASF SE, Armacell International, SA, Bayer AG, Foamcraft, Inc., Foampartner Group, Future Foam, Inc., Fxi-Foamex Innovations, Inoac Corporation, Recticel Nv/Sa, Rogers Corporation, Sekisui Chemical Co., Ltd., The DOW Chemical Company, Trelleborg AB, UFP Technologies, Inc., The Vita Group (UK) and among others. Key strategies implemented by major players in Medical Foam market to improve the revenue are new product launch and acquisitions with other organizations to improve the market growth.
Why to buy this report: